期刊文献+

中心型非小细胞肺癌浸润近端支气管壁的临床病理学研究 被引量:3

Clinicopathological Study of Proximal Bronchial Extension in Hilar Type Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的:观察中心型非小细胞肺癌不同的病理组织学类型、pTNM分期、p53蛋白表达对癌细胞浸润近端支气管壁长度的影响,为术式的选择提供临床病理依据。方法:收集86例原发性中心型非小细胞肺癌的手术标本,对肿瘤至支气管切缘的管壁进行连续取材,观察组织学类型,测量癌细胞浸润近端支气管的长度。用免疫组织化学法(SP)检测p53蛋白表达。结果:Ⅲa期腺癌最长(1.91±0.36cm),Ⅰb期鳞癌最短(0.39±0.15cm)。p53蛋白阳性表达者浸润长度(0.87±0.49cm)大于表达阴性者(0.53±0.32cm),(t=3.82,P<0.01),且差异均有显著性。结论:在原发性中心型非小细胞肺癌中,病理组织学类型、pTNM分期及p53蛋白表达与癌细胞浸润近端支气管壁的长度有关,可作为选择术式的依据之一。 Objective: To investigate the effects of proximal bronchial extension of hilar type non-small cell lung cancer (NSCLC) of different types, pTNM stages and expression of p53 protein and provide a clinicopathological basis for a curative resection. Methods: Eighty-six surgical specimens of primary hilar type NSCLC were collected for this study. Macroscopic and microscopic proximal bronchial invasion lengths were measured from bronchial resection margins to tumor edges. The expression of p53 protein was determined in all cases of primary hilar type NSCLC by immunohistochemical technique. Results: The invasion length of Adenocarcinomas at stage Ⅲa was the longest (1.91±0.36cm) and that of Squamous cell carcinomas at stage Ⅰb was the shortest (0.39±0.15cm). The positive expressions of p53 protein (0.87±0.49cm) was much longer than that of negative ones(0.53±0.32cm), which was significantly different (t=3.82, P<0.01). Conclusion: The extension of invasion is correlated with the histopathologic type of cancer, TNM classification and p53 expression, which are one of clinicopathological bases for a curative resection.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2004年第21期1204-1208,共5页 Chinese Journal of Clinical Oncology
基金 天津市卫生局科研基金资助(编号:94KY-GG20)
关键词 非小细胞肺癌 病理组织学类型 pTNM分期 P53蛋白 肿瘤浸润 Non-small cell lung cancer(NSCLC) Histopathologic type pTNM stage P53 protein Neoplasm invasion
  • 相关文献

参考文献10

  • 1[1]Hofmann HS, Taege C, Lautenschlager C, et al. Microscopic(R1)residual disease in patients with resected non-small cell lung cancer[J]. Eur J Cardiothorac Surg, 2002, 21 (4):606~ 610
  • 2[2]Passlick B, Sitar I, Sienel W, et al. Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer [J]. Ann Thorac Surg, 2001, 72(4):1160~1164
  • 3[3]Kayser K, Anyanwu E, Bauer HG, et al. Tumor presence at resection boundaries and lymph-node metastasis in bronchial carcinoma patients[J]. Thorac Cardiovasc Surg, 1993, 41(5):308~311
  • 4[4]Wistuba Ⅱ, Gazdar AF, Minna JD. Molecular genetics of small cell lung carcinoma[J]. Semin Oncol, 2001, 28(2 Suppl 4):3~13
  • 5刘坤平,莫鉴锋,谢芝香,胡国洪,原伟权,张永东,叶勇.结直肠癌mdm2、p21和p53蛋白的表达[J].中华病理学杂志,2000,29(1):69-69. 被引量:8
  • 6许金良,于庆凯,刘先本,吉庆明,高宗人,龙志强,乔思杰.肺癌侵袭近端支气管壁的临床病理探讨[J].中华肿瘤杂志,1998,20(6):448-450. 被引量:9
  • 7曲家骐 李厚文 等.肺癌沿支气管壁浸润范围和方式的研究[J].中华肿瘤杂志,1986,8:193-193.
  • 8[8]Tananka F, Yanagihara K, Otake Y, et al. Prognostic factors in patients with resected pathologic (p-) T1-2N1MO non-small cell lung cancer (NSCLC)[J]. EurJ Cardiothorac Surg, 2001, 19(5) :555 ~ 561
  • 9[9]Niklinska W, Burzykowski T, Chyczewski L, et al. Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis[J]. Lung Cancer, 2001, 34(Suppl 2):S59~64
  • 10[10]Tanaka F, Otake Y, Yanagihara K, et al. Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer[J]. BrJ Cancer, 2001, 84(2):263~269

二级参考文献5

  • 1高成新,黄偶麟,周允中,吴松昌,孙德魁,荣正柏.袖状肺叶切除术治疗中心型肺癌155例分析[J].中华胸心血管外科杂志,1994,10(4):320-321. 被引量:35
  • 2曲家骐,中华肿瘤杂志,1986年,3期,193页
  • 3Yasui W,Akama Y,Yokozaki H,et al.Expression of p21WAF1 CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression[].Pathology International.1997
  • 4ValassiadouKE,StefanakiK,TzardiM,etal.Immunohistochemicalex pressionofp5 3 ,bcl 2 ,mdm2andwaf1 p2 1proteinsincolorectaladeno carcinomas[].Anticancer Research.1997
  • 5Hao XP,Gunther T,Roessner A,et al.Expression of mdm2 and p53 in epithelial neoplasms of the colorectum[].Molecular Pathology.1998

共引文献22

同被引文献25

  • 1曾会昌.肺癌切除支气管切缘癌残留27例报告[J].临床外科杂志,1995,3(4):204-205. 被引量:4
  • 2贾世峰,董驹.支气管切缘癌相关因素研究的进展[J].华北煤炭医学院学报,2006,8(3):327-329. 被引量:2
  • 3Shimosato Y.Histological Typing of Lung and Pleural Tumors(3rd edition, 1999):Malignant epithelial tumors.Nippon Rinsho,2002,60(suppl 5):123-129.
  • 4Mounatain CF.Revision in the inaternational system for staging lung cancer. Chest, 1997,111 (6): 1710-1717.
  • 5Jichen QV,Chen G,Jiang G,et al.Risk factor comparison and clinical analysis of early and late bronchopleural fostula after non-small cell lung cancer surgery.Ann Thoral Surg,2009,88(5):1589-1593.
  • 6Panagopoulos ND,Apostolakis E.Low incidence of bronchopleural fostula after pneumonectomy for lung cancer.Interact Cardiovasc Thorac Surg, 2009,9(4):571-575.
  • 7Graham ANJ,Chan KJM,Pastorimo U,et al.Syste rnaticnodal dissection in the intrathoracic staging of patients with non-small cell lung cancer.J Thorac Cardiovasc Surg,1999,117(2):246-251.
  • 8Kara M,Sak SD,Orhan D,et al.Changing patterns of lung cancer(3/4 in)1.9cm still a safe length forbronchial resection margin.Lung Cancer, 2000,30(3):161-167.
  • 9Ghiribelli C, Voltolini L, Paladini P, et al. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump [ J ]. Eur J Cardiothorae Surg, 1999, 16(5):555-559.
  • 10Mehran R J, Deslauriers J, Piraux M, et al. Survival related to nodal status after sleeve resection for lung cancer[ J]. J Thorac Cardiovasc Surg, 1994,107 (2) : 576-582; discussion 582-583.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部